Introduction：Basic information about CAS 41607-20-9|(-)-Pinoresinol 4-O-glucoside, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | (-)-Pinoresinol 4-O-glucoside |
|---|
| CAS Number | 41607-20-9 | Molecular Weight | 520.53 |
|---|
| Density | 1.4±0.1 g/cm3 | Boiling Point | 752.5±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C26H32O11 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 408.9±32.9 °C |
|---|
Names
| Name | (2S,3R,4S,5S,6R)-2-(4-((1R,3aS,4R,6aS)-4-(4-hydroxy-3-methoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl)-2-methoxyphenoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|---|
| Synonym | More Synonyms |
|---|
(-)-Pinoresinol 4-O-glucoside BiologicalActivity
| Description | (-)-Pinoresinol 4-O-glucoside ((-)-Pinoresinol 4-O-β-D-glucopyranoside) is a potent and orally active α-glucosidase inhibitor with an IC50 value of 48.13 µM. (-)-Pinoresinol 4-O-glucoside increases cell migration and early differentiation of pre-osteoblasts. (-)-Pinoresinol 4-O-glucoside increases protein level of BMP2, p-Smad1/5/8, RUNX2. (-)-Pinoresinol 4-O-glucoside attenuates oxidative stress, hyperglycemia and hepatic toxicity. (-)-Pinoresinol 4-O-glucoside has the potential for the research of osteoporosis and periodontal disease[1][2]. |
|---|
| Related Catalog | Research Areas >>Metabolic Disease |
|---|
| Target | IC50: 48.13 µM (α-Glucosidase)[1] |
|---|
| In Vitro | (-)-Pinoresinol 4-O-glucoside (0、10、30 µM；24 小时) 在含有 50 μg/mL 的成骨补充培养基 (OS) 中增加前成骨细胞分化过程中的细胞迁移[1]< /sup>. (-)-Pinoresinol 4-O-glucoside (10、30 µM；7 天) 在前成骨细胞分化过程中增加早期分化并增加矿化结节的形成[1]。 (-)-Pinoresinol 4-O-glucoside (10、30 µM；3 天) 增加前成骨细胞中 BMP2、ALP、OCN mRNA 水平的表达[1]。 (-)-Pinoresinol 4-O-glucoside (10、30 µM；3 天) 增加 BMP2、p-Smad1/5/8、RUNX2 的蛋白表达水平[1]。 RT-PCR[1] Cell Line: pre-osteoblasts Concentration: 10, 30 µM Incubation Time: 3 days Result: Upregulated the mRNA level of BMP2 and its target osteoblast genes, ALP and osteocalcin (OCN). Western Blot Analysis[1] Cell Line: pre-osteoblasts Concentration: 10, 30 µM Incubation Time: 3 days Result: Enhanced protein level of BMP2, followed by the phosphorylation of Smad1/5/8 and the expression of RUNX2. |
|---|
| In Vivo | (-)-Pinoresinol 4-O-glucoside (50 mg/kg；口服；20 天) 减轻小鼠的氧化应激、高血糖和肝毒性[2]。 Animal Model: 27-30 g, Male Swiss albino mice[2] Dosage: 50 mg/kg Administration: P.o.; twenty days Result: Exhibited a hepatoprotective activity in vivo as it lowered AST and ALT levels, caused a prominent decline in serum glucose level by 37.83% in streptozotocin-treated mice with promising elevation in insulin level of 25.37%. |
|---|
| References | [1]. Park KR, et al. Effects of PIN on Osteoblast Differentiation and Matrix Mineralization through Runt-Related Transcription Factor. Int J Mol Sci. 2020 Dec 16;21(24):9579. [2]. Youssef FS, et al. Pinoresinol-4-O-β-D-glucopyranoside: a lignan from prunes (Prunus domestica) attenuates oxidative stress, hyperglycaemia and hepatic toxicity in vitro and in vivo. J Pharm Pharmacol. 2020 Dec;72(12):1830-1839. |
|---|
Chemical & Physical Properties
| Density | 1.4±0.1 g/cm3 |
|---|
| Boiling Point | 752.5±60.0 °C at 760 mmHg |
|---|
| Molecular Formula | C26H32O11 |
|---|
| Molecular Weight | 520.53 |
|---|
| Flash Point | 408.9±32.9 °C |
|---|
| Exact Mass | 520.194458 |
|---|
| PSA | 156.53000 |
|---|
| LogP | -0.69 |
|---|
| Vapour Pressure | 0.0±2.6 mmHg at 25°C |
|---|
| Index of Refraction | 1.619 |
|---|
| InChIKey | QLJNETOQFQXTLI-JKUDBEEXSA-N |
|---|
| SMILES | COc1cc(C2OCC3C(c4ccc(OC5OC(CO)C(O)C(O)C5O)c(OC)c4)OCC23)ccc1O |
|---|
Safety Information
Synonyms
| 4-[(1R,3aS,4R,6aS)-4-(4-Hydroxy-3-methoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl β-D-glucopyranoside |
| β-D-Glucopyranoside, 2-methoxy-4-[(1R,3aS,4R,6aS)-tetrahydro-4-(4-hydroxy-3-methoxyphenyl)-1H,3H-furo[3,4-c]furan-1-yl]phenyl |
